A new study examining the associations between racial and ethnic discrimination and COVID-19 vaccine refusal has found that one in ten people from ethnic minority groups who refused a vaccine experienced racial discrimination in a medical setting since the start of the pandemic.
Pfizer has NOT declared their COVID vaccines unsafe for pregnancy and breastfeeding women, despite misleading claims on social media, nor have they said that the real efficacy rate for their vaccine (COMIRNATY) is 12 percent.
While planning for an overseas adventure, it’s important to include a few key preventative measures to help keep you healthy during your travels, like getting the appropriate shots and packing the right medications.
A newly published analysis in the Journal of the American College of Cardiology of hospitalized patients with both a severe type of heart attack called STEMI (ST-elevation myocardial infarction) and coronavirus disease-19 (COVID-19) infection compares clinical outcomes for these patients during the first and second years of the COVID-19 pandemic.
If you’re wondering why after two vaccination doses and a booster shot, you still got sick from the omicron strain of the virus that causes COVID-19, one possible answer may have been found in a recent study by researchers at Johns Hopkins Medicine and the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health (NIH).
Ted Ross, Ph.D., has been appointed Global Director of Vaccine Development at Cleveland Clinic. In this newly created role, he will lead the development of novel vaccine platforms for a variety of infectious diseases, including influenza, HIV and COVID-19. A highly renowned scientist with expertise in virology, vaccines, immunology and microbiology, Dr. Ross’ research focuses on the design of new vaccines and the implementation of new vaccine trials.
Vaccination policy, vaccine hesitancy and post-vaccination symptoms and effects among top topics tweeted
Scholars from HSE University and the RAS Institute of Bioorganic Chemistry have demonstrated the efficiency of T-cell immune response against the Omicron variant of SARS-CoV-2.
Irvine, Calif., April 27, 2022 – Philip Felgner, Ph.D., professor in residence of physiology & biophysics at the University of California, Irvine, is one of two scholars to win the prestigious 2022 Robert Koch Prize for fundamental contributions to the transfer of nucleic acids into cells. This pioneering technology for treating infectious diseases played a crucial role in developing the messenger RNA COVID-19 vaccines.
National Comprehensive Cancer Network Advisory Committee on COVID-19 Vaccination and Pre-exposure Prophylaxis provides expert consensus to help guide cancer care providers on latest research, available at NCCN.org/covid-19.
Unvaccinated people threaten the safety of the vaccinated even when SARS-Cov-2 vaccination rates are high, according to a new modelling study published in CMAJ (Canadian Medical Association Journal)
The Innovation Studio at Children’s Hospital Los Angeles, in partnership with the Los Angeles County Department of Public Health, has selected three teams as the winners of the VaxUp Innovation Challenge, the culmination of a three-month program to generate, test and scale creative solutions to increase COVID-19 vaccination rates among children and teens in Los Angeles County.
Johns Hopkins will welcome Atul Gawande, assistant administrator of the Bureau for Global Health at the United States Agency for International Development, for a virtual conversation with Ellen J. MacKenzie, dean of the Johns Hopkins Bloomberg School of Public Health.
Researchers at Lund University and Uppsala University are conducting one of the largest citizen science projects in Sweden to date.
A point-of-care COVID-19 test developed by researchers at the University of Illinois Urbana-Champaign can now detect and differentiate the alpha variant of the SARS-CoV-2 virus from earlier strains in saliva samples.
Results of a new multicenter study published in the New England Journal of Medicine found that vaccination with a primary series of the Pfizer-BioNTech mRNA COVID-19 vaccine reduced the risk of COVID-19-associated hospitalizations in children ages 5–11 years by two-thirds during the Omicron period.
New research from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King’s College London has assessed parental preference for a mandatory childhood vaccination scheme and finds that, when rating different options for a mandatory vaccination scheme, the incentives for vaccinating, and penalties for not vaccinating, were the most influential factors in parents’ decisions.
Pregnant women continue to have reservations about getting vaccinated against COVID-19 despite research indicating the safety of the vaccines and the protection they may offer their unborn children.
The antibodies generated by Pfizer’s COVID-19 vaccine rise more slowly and decline more quickly than those generated by the Moderna vaccine, according to a new study from UVA Health.
Researchers at The University of Adelaide have found that the meningococcal B vaccine could improve protection against gonorrhoea in addition to protection against meningococcal B meningitis.
CoVac-1, a new vaccine against SARS-CoV-2, induced T-cell immune responses in 93 percent of patients with B-cell deficiencies, including many patients with leukemia and lymphoma, according to results presented at the AACR Annual Meeting 2022, held April 8-13.
University of Maryland School of Medicine’s Institute of Human Virology contributes to Global Virus Network studies suggesting that the oral polio vaccine can protect people in developing nations that do not yet have access to COVID vaccines
Rutgers researchers are calling for a change in our approach to developing COVID-19 vaccines, and vaccines to fight future pandemics, to incorporate both conventional and challenge trails.
Safe dietary supplements developed at Tel Aviv University might help protect the body against Covid-19 and a range of winter illnesses.
COVID-19 vaccines taken by people with inflammatory bowel disease (IBD), which affects millions worldwide, safely and effectively protects them from the SARS-Cov-2 virus, a Rutgers study finds.
Health officials have observed an increased risk for heart inflammation in adolescents and young adults who have received either the Moderna or Pfizer-BioNTech vaccines. Three expert physicians share the facts on this rare reaction—and why vaccinating your child is still the safest choice.
In the 21st century, the internet and particularly social media have become essential platforms for the spread of health information (including misinformation and disinformation). One of the distinguishing features of communication on these platforms...
UC San Diego has joined a Phase II clinical trial to evaluate various additional COVID-19 booster shots. The trial seeks to understand if different vaccine regimens can broaden immune responses in adults who already have received a primary vaccination series and a first booster shot.
Most immunocompromised people with a blood cancer called multiple myeloma benefited from a third dose of COVID-19 vaccines, a promising sign after it was shown that two doses tended to not be sufficient for them. However, some people with multiple myeloma still remained vulnerable and may need a fourth dose or antibody treatments as restrictions lift and new variants emerge, according to a fast-tracked study in Cancer Cell.
Indiana University will further develop a new technology for a combination oral rotavirus-norovirus vaccine for infants, thanks to a $1.2 million grant from venture capital firm GIVAX Inc.
Scientists analyzed ultrasounds for a wide range of birth defects from life-long and severe to short-term and mild
_RGB Blue20230706101098.jpg&width=400&height=400)
New research from the Case Western Reserve University (CWRU) School of Medicine suggests that the children younger than age 5 who are infected with the COVID-19 Omicron variant have less risk of severe health outcomes than those infected with the Delta variant.
In a paper in the journal Nature, Los Alamos National Laboratory scientists Bette Korber, Hyejin Yoon, Will Fischer and James Theiler, among nearly 130 authors from institutions around the world, describe their groundbreaking collaborative work, “Defining the risk of SARS-CoV-2 variants on immune protection.”
Many people who do not usually menstruate reported experiencing breakthrough bleeding or other period symptoms after receiving a COVID-19 vaccine, according to new findings from an online survey by researchers at Washington University in St. Louis.
Two new studies from the Global Virus Network (GVN) in partnership with the Petroleum Industry Health Organization of Iran provide evidence that getting the oral polio vaccine made from live, weakened poliovirus may protect people from COVID-19 infection by stimulating the immune system.
Transmission of SARS-CoV-2 has led to the ongoing global COVID-19 pandemic. By February 2022, more than 400 million have had confirmed COVID-19 and more than five million have died worldwide.
With second boosters becoming available, schedules for first boosters recently changed, and new evidence about the protection offered by boosters in the Omicron surge, a guide for those who have not yet been boosted or are considering a second booster.
Background: The development and approval of COVID-19 vaccines have generated optimism for the end of the COVID-19 pandemic and a return to normalcy. However, vaccine hesitancy, often fueled by misinformation, poses a major barrier to...
Vaccine uptake constitutes a key barometer as governments lead the communities out of the COVID-19 pandemic. Facts and fake news have apparently influenced vaccination willingness. But how valid is this proposition?
Reporters are invited to join a live discussion of research announcements at the forefront of the life sciences during a virtual press conference for the Experimental Biology (EB) 2022 meeting. The press conference will be held online from 11–11:45 a.m. Eastern on Friday, April 1, 2022 (RSVP by Thursday, March 31).
Board-certified dermatologist provides the latest information on how COVID and its vaccines affect people’s skin
Vaccination against COVID-19 during pregnancy is not associated with a higher risk of pregnancy complications, according to a large-scale registry study from Karolinska Institutet in Sweden and the Norwegian Institute of Public Health published in the journal JAMA.
Despite daily contact with Covid-19 patients early in the pandemic, some health professionals avoided falling ill. As a University of Gothenburg study shows, the explanation appears to be an antidote in the immune system: IgA antibodies to COVID-19.
Pancreatic cancer is notoriously difficult to cure or even treat. Now, a new strategy devised by scientists at Albert Einstein College of Medicine has succeeded in making pancreatic tumors visible to the immune systems of mice and vulnerable to immune attack, reducing cancer metastases by 87%. The paper describing the findings published online today in Science Translational Medicine.
The new study suggests that children tend to have strong antibody responses after SARS-CoV-2 infection. Understanding antibody responses to SARS-CoV-2 at different ages can inform COVID-19 vaccine strategies and policies.
The dramatic toll that COVID-19 has taken on the U.S. is apparent, but as caseloads come down and mandates are loosened it has become increasingly obvious how much of an impact the pandemic had on food service workers in industries like the fisheries. A study from the University of New Hampshire looked at the direct and indirect effects of the global pandemic on U.S. seafood workers by tracking cases and outbreaks and found seafood workers were twice as likely to contract COVID-19 as workers in other food industries.
A team of clinical investigators at the Icahn School of Medicine at Mount Sinai has announced the launch of a Phase 1, open-label, placebo-controlled study to evaluate the safety and immunogenicity of an egg-based COVID-19 vaccine in healthy, vaccinated adults who have never been infected with COVID-19.
Our immune protection is provided by two systems working hand in hand. When infected with a virus, the immune system reacts by producing antibodies that can prevent the virus from infecting further cells.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
